Opaleye Management as of June 30, 2021
Portfolio Holdings for Opaleye Management
Opaleye Management holds 48 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 15.3 | $92M | 6.5M | 14.18 | |
| Chimerix (CMRX) | 6.2 | $37M | 4.6M | 8.00 | |
| Celldex Therapeutics Com New (CLDX) | 5.5 | $33M | 985k | 33.44 | |
| Bridgebio Pharma (BBIO) | 5.2 | $32M | 517k | 60.96 | |
| Codexis (CDXS) | 5.1 | $31M | 1.3M | 22.66 | |
| Eton Pharmaceuticals (ETON) | 4.9 | $29M | 3.7M | 7.94 | |
| Harrow Health (HROW) | 4.8 | $29M | 3.1M | 9.29 | |
| Protara Therapeutics Com Stk (TARA) | 4.1 | $25M | 2.6M | 9.74 | |
| Stereotaxis Com New (STXS) | 4.0 | $24M | 2.5M | 9.64 | |
| Tracon Pharmaceuticals Com New | 2.7 | $16M | 2.5M | 6.49 | |
| Kiniksa Pharmaceuticals Com Cl A | 2.7 | $16M | 1.2M | 13.93 | |
| Macrogenics (MGNX) | 2.6 | $16M | 578k | 26.86 | |
| Protagonist Therapeutics (PTGX) | 2.5 | $15M | 330k | 44.88 | |
| Fortress Biotech | 2.3 | $14M | 3.9M | 3.57 | |
| Xoma Corp Del Com New (XOMA) | 1.9 | $12M | 344k | 34.00 | |
| Cytokinetics Com New (CYTK) | 1.9 | $12M | 580k | 19.79 | |
| Neoleukin Therapeutics | 1.8 | $11M | 1.2M | 9.23 | |
| Acutus Medical (AFIB) | 1.7 | $10M | 600k | 16.98 | |
| Keros Therapeutics (KROS) | 1.7 | $10M | 235k | 42.47 | |
| Verastem | 1.6 | $9.5M | 2.3M | 4.07 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 1.5 | $9.3M | 1.4M | 6.74 | |
| Sutro Biopharma (STRO) | 1.5 | $9.2M | 497k | 18.59 | |
| Adamas Pharmaceuticals | 1.5 | $8.8M | 1.7M | 5.28 | |
| Essa Pharma Com New (EPIX) | 1.3 | $8.1M | 284k | 28.57 | |
| Vaxcyte (PCVX) | 1.3 | $8.1M | 358k | 22.51 | |
| Deciphera Pharmaceuticals | 1.2 | $7.5M | 205k | 36.61 | |
| Larimar Therapeutics (LRMR) | 1.2 | $7.1M | 728k | 9.82 | |
| Tela Bio (TELA) | 1.2 | $7.1M | 441k | 16.11 | |
| Seres Therapeutics | 1.0 | $6.0M | 250k | 23.85 | |
| Sio Gene Therapies Common | 0.9 | $5.3M | 2.0M | 2.63 | |
| Cm Life Sciences Com Cl A | 0.9 | $5.2M | 374k | 14.01 | |
| Cerecor | 0.9 | $5.1M | 1.6M | 3.27 | |
| Mei Pharma Com New | 0.7 | $4.5M | 1.6M | 2.85 | |
| Aveo Biosciences Com New | 0.7 | $4.3M | 647k | 6.59 | |
| Forma Therapeutics Holdings SHS | 0.7 | $4.3M | 171k | 24.89 | |
| Lumos Pharma | 0.6 | $3.8M | 382k | 10.00 | |
| Optinose | 0.6 | $3.8M | 1.2M | 3.11 | |
| Kezar Life Sciences | 0.6 | $3.8M | 698k | 5.43 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.6 | $3.8M | 201k | 18.85 | |
| Aptose Biosciences Com New | 0.5 | $3.3M | 980k | 3.32 | |
| Sierra Oncology Com New | 0.5 | $3.2M | 166k | 19.47 | |
| Cardiff Oncology (CRDF) | 0.5 | $3.1M | 463k | 6.65 | |
| Viracta Therapeutics (VIRX) | 0.5 | $2.9M | 257k | 11.34 | |
| Pharvaris N V (PHVS) | 0.2 | $1.5M | 80k | 18.63 | |
| Leap Therapeutics | 0.1 | $886k | 540k | 1.64 | |
| Contrafect Corp Com New | 0.0 | $255k | 58k | 4.40 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $148k | 73k | 2.02 | |
| Biolinerx Sponsored Ads | 0.0 | $47k | 17k | 2.82 |
